NEURO61

Session information

Print

Hot Topics

[HT-03] Hot Topics 03
Dawn of new era: management of migraine headache

Mon. Aug 31, 2020 1:30 PM - 3:00 PM Room 1 (OKAYAMA CONVENTION CENTER 4F 405)

Chair：KoichiHirata（Department of Neurology, Dokkyo Medical University）,YasuoTerayama（Neurological Institute, Shonan Keiiku Hospital）

[HT-03-1] Current migraine management

○Hisaka Igarashi (Headache Unit, Department of Internal Medicine, Fujitsu Clinic, Japan)

Although triptans and some prophylactic medications are currently available, some unmet needs of migraine managements remain to be resolved. Now some lineup of new molecules, devices and methods are developing to be served for practical clinical settings. This symposium will review the new lineups by top headache experts.

[HT-03-2] Anti-CGRP antibodies

○David W. Dodick (Mayo Clinic, USA)

Although triptans and some prophylactic medications are currently available, some unmet needs of migraine managements remain to be resolved. Now some lineup of new molecules, devices and methods are developing to be served for practical clinical settings. This symposium will review the new lineups by top headache experts.

[HT-03-3] Gepants and lasmiditan: novel players in acute migraine treatment

○Mamoru Shibata (Department of Neurology, Keio University School of Medicine, Japan)

Although triptans and some prophylactic medications are currently available, some unmet needs of migraine managements remain to be resolved. Now some lineup of new molecules, devices and methods are developing to be served for practical clinical settings. This symposium will review the new lineups by top headache experts.

[HT-03-4] Devices (Cefaly/gammaCore)

○Daisuke Danno (Headache center, Department of Neurology, Tominaga hospital, Japan)

Although triptans and some prophylactic medications are currently available, some unmet needs of migraine managements remain to be resolved. Now some lineup of new molecules, devices and methods are developing to be served for practical clinical settings. This symposium will review the new lineups by top headache experts.

[HT-03-5] Multidisciplinary team approaches for intractable chronic pain

○Takahiro Ushida, Chronic Pain Policy Research Group of MHLW (Multidisciplinary Pain Center, Aichi Medical University, Japan)

Although triptans and some prophylactic medications are currently available, some unmet needs of migraine managements remain to be resolved. Now some lineup of new molecules, devices and methods are developing to be served for practical clinical settings. This symposium will review the new lineups by top headache experts.